Figure 2
Figure 2. Steady-state plasma lestaurtinib levels. Individual plasma lestaurtinib levels determined 12 hours after the most recent dose on or within 2 days of day 15 (aplasia assessment) and day 42 (outcome assessment). The horizontal lines indicate the mean levels for each time point.

Steady-state plasma lestaurtinib levels. Individual plasma lestaurtinib levels determined 12 hours after the most recent dose on or within 2 days of day 15 (aplasia assessment) and day 42 (outcome assessment). The horizontal lines indicate the mean levels for each time point.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal